Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2011-6-23
pubmed:abstractText
Activation of inflammatory cells is central to the pathogenesis of autoimmune demyelinating diseases of the peripheral nervous system. The novel chimeric compound quinpramine--generated from imipramine and quinacrine--redistributes cholesterol rich membrane domains to intracellular compartments. We studied the immunological and clinical effects of quinpramine in myelin homogenate induced Lewis rat experimental autoimmune neuritis (EAN), a model system for acute human inflammatory neuropathies, such as the Guillain-Barré syndrome. EAN animals develop paresis of all limbs due to autoimmune inflammation of peripheral nerves. Quinpramine treatment ameliorated clinical disease severity of EAN and infiltration of macrophages into peripheral nerves. It reduced expression of MHC class II molecules on antigen presenting cells and antigen specific T cell proliferation both in vitro and in vivo. Quinpramine exerted its anti-proliferatory effect on antigen presenting cells, but not on responder T cells. Our data suggest that quinpramine represents a candidate pharmaceutical for inflammatory neuropathies.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/21698177-11024541, http://linkedlifedata.com/resource/pubmed/commentcorrection/21698177-11244041, http://linkedlifedata.com/resource/pubmed/commentcorrection/21698177-12352006, http://linkedlifedata.com/resource/pubmed/commentcorrection/21698177-1538783, http://linkedlifedata.com/resource/pubmed/commentcorrection/21698177-15554919, http://linkedlifedata.com/resource/pubmed/commentcorrection/21698177-16271648, http://linkedlifedata.com/resource/pubmed/commentcorrection/21698177-16510744, http://linkedlifedata.com/resource/pubmed/commentcorrection/21698177-16611580, http://linkedlifedata.com/resource/pubmed/commentcorrection/21698177-16749906, http://linkedlifedata.com/resource/pubmed/commentcorrection/21698177-17064077, http://linkedlifedata.com/resource/pubmed/commentcorrection/21698177-17262851, http://linkedlifedata.com/resource/pubmed/commentcorrection/21698177-17337484, http://linkedlifedata.com/resource/pubmed/commentcorrection/21698177-17410107, http://linkedlifedata.com/resource/pubmed/commentcorrection/21698177-17537676, http://linkedlifedata.com/resource/pubmed/commentcorrection/21698177-17853872, http://linkedlifedata.com/resource/pubmed/commentcorrection/21698177-18657574, http://linkedlifedata.com/resource/pubmed/commentcorrection/21698177-18996373, http://linkedlifedata.com/resource/pubmed/commentcorrection/21698177-19088488, http://linkedlifedata.com/resource/pubmed/commentcorrection/21698177-19544394, http://linkedlifedata.com/resource/pubmed/commentcorrection/21698177-19914379, http://linkedlifedata.com/resource/pubmed/commentcorrection/21698177-20603652, http://linkedlifedata.com/resource/pubmed/commentcorrection/21698177-6159457, http://linkedlifedata.com/resource/pubmed/commentcorrection/21698177-7224616, http://linkedlifedata.com/resource/pubmed/commentcorrection/21698177-9064603
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1932-6203
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
6
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
e21223
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Quinpramine ameliorates rat experimental autoimmune neuritis and redistributes MHC class II molecules.
pubmed:affiliation
Department of Neurology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany. gerd.mzh@uni-duesseldorf.de
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't